Page last updated: 2024-09-05

paromomycin and Co-infection

paromomycin has been researched along with Co-infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alirol, E; Alvar, J; Alves, F; Balasegaram, M; Chappuis, F; Diro, E; Ellis, S; Hailu, A; Jameneh, A; Khalil, EA; Kimutai, R; Makonnen, E; Mohammed, R; Musa, AM; Musa, B; Njoroge, S; Okello, L; Olobo, J; Omollo, R; Rashid, J; Ritmeijer, K; Sagaki, P; Salman, K; Soipei, P; Strub, N; Wasunna, M1
Croft, SL; Olliaro, P1

Reviews

1 review(s) available for paromomycin and Co-infection

ArticleYear
Leishmaniasis chemotherapy--challenges and opportunities.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:10

    Topics: Anti-HIV Agents; Antiprotozoal Agents; Clinical Trials as Topic; Coinfection; Drug Discovery; HIV; HIV Infections; Humans; India; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Paromomycin; Research

2011

Other Studies

1 other study(ies) available for paromomycin and Co-infection

ArticleYear
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
    Clinical drug investigation, 2017, Volume: 37, Issue:3

    Topics: Administration, Intravenous; Adolescent; Adult; Africa, Eastern; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Paromomycin; Pharmacovigilance; Prospective Studies; Recurrence; Treatment Outcome; Young Adult

2017